Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes

Virus Research

Volumn 123, Issue 2, 2007, Pages 120-127

  Hayasaka, Daisuke ^a   Maeda, Ken ^a   Ennis, Francis A ^a   Terajima, Masanori ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cytotoxic T lymphocyte; Endothelial cell; Hantavirus pulmonary syndrome; Hemorrhagic fever with renal syndrome; Sin Nombre virus; Transwell permeability assay

Indexed keywords

EPITOPE; HLA A24 ANTIGEN; PROTEIN G2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CAPILLARY LEAK SYNDROME; CELL LINE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENDOTHELIUM CELL; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMAN; HUMAN CELL; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUUMALA VIRUS; SIN NOMBRE VIRUS; VIRUS HEMORRHAGIC FEVER;

CELL LINE; ENDOTHELIAL CELLS; HANTAVIRUS PULMONARY SYNDROME; HLA-A ANTIGENS; HUMANS; PERMEABILITY; SIN NOMBRE VIRUS; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

ADENOVIRIDAE; HANTAVIRUS; PUUMALA VIRUS; SIN NOMBRE VIRUS;

EID: 33846027112     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2006.08.006     Document Type: Article

References (52)

1. Chen L.B., and Yang W.S. Abnormalities of T cell immunoregulation in hemorrhagic fever with renal syndrome. J. Infect. Dis. 161 5 (1990) 1016-1019
2. Co M.D., Terajima M., Cruz J., Ennis F.A., and Rothman A.L. Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology 293 1 (2002) 151-163
3. Edgell C.J., McDonald C.C., and Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridisation. Proc. Natl. Acad. Sci. U.S.A. 80 12 (1983) 3734-3737
4. Ennis F.A., Cruz J., Spiropoulou C.F., Waite D., Peters C.J., Nichol S.T., Kariwa H., and Koster F.T. Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virology 238 2 (1997) 380-390
5. Ennis P.D., Zemmour J., Salter R.D., and Parham P. Rapid cloning of HLA-A, B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification. Proc. Natl. Acad. Sci. U.S.A. 87 7 (1990) 2833-2837
6. Enria D.A., Briggiler A.M., Pini N., and Levis S. Clinical manifestations of New World hantaviruses. Curr. Top. Microbiol. Immunol. 256 (2001) 117-134
7. Enserink M. Virology. Finally, a handle on the hantaviruses. Science 293 5534 (2001) 1414-1415
8. Gavrilovskaya I.N., Peresleni T., Geimonen E., and Mackow E.R. Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration. Arch. Virol. 147 10 (2002) 1913-1931
9. Geimonen E., Neff S., Raymond T., Kocer S.S., Gavrilovskaya I.N., and Mackow E.R. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc. Natl. Acad. Sci. U.S.A. 99 21 (2002) 13837-13842
10. Hautala T., Sironen T., Vapalahti O., Paakko E., Sarkioja T., Salmela P.I., Vaheri A., Plyusnin A., and Kauma H. Hypophyseal hemorrhage and panhypopituitarism during Puumala Virus Infection: Magnetic resonance imaging and detection of viral antigen in the hypophysis. Clin. Infect. Dis. 35 1 (2002) 96-101
11. Hooper J.W., Kamrud K.I., Elgh F., Custer D., and Schmaljohn C.S. DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection. Virology 255 2 (1999) 269-278
12. Hooper J.W., Larsen T., Custer D.M., and Schmaljohn C.S. A lethal disease model for hantavirus pulmonary syndrome. Virology 289 1 (2001) 6-14
13. Huang C., Jin B., Wang M., Li E., and Sun C. Hemorrhagic fever with renal syndrome: relationship between pathogenesis and cellular immunity. J. Infect. Dis. 169 4 (1994) 868-870
14. Jonsson C.B., and Schmaljohn C.S. Replication of hantaviruses. Curr. Top. Microbiol. Immunol. 256 (2001) 15-32
15. Kang J.I., Park S.H., Lee P.W., and Ahn B.Y. Apoptosis is induced by hantaviruses in cultured cells. Virology 264 1 (1999) 99-105
16. Koster F., Vigil J., Olson D., Terajima M., Ennis F., Moehenkamp C., and Williams T. Class I, II and III HLA alleles associated with severe hantavirus cardiopulmonary syndrome in the southwest US. Am. J. Trop. Med. 65 3 (2001) 152 (meeting abstract)
17. Khaiboullina S.F., Netski D.M., Krumpe P., and St Jeor S.C. Effects of tumor necrosis factor alpha on Sin Nombre virus infection in vitro. J. Virol. 74 24 (2000) 11966-11971
18. Khaiboullina S.F., and St Jeor S.C. Hantavirus immunology. Viral Immunol. 15 4 (2002) 609-625
19. Kilpatrick E.D., Terajima M., Koster F.T., Catalina M.D., Cruz J., and Ennis F.A. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J. Immunol. 172 5 (2004) 3297-3304
20. Lewis R.M., Lee H.W., See A.F., Parrish D.B., Moon J.S., Kim D.J., and Cosgriff T.M. Changes in populations of immune effector cells during the course of haemorrhagic fever with renal syndrome. Trans. R. Soc. Trop. Med. Hyg. 85 2 (1991) 282-286
21. Li X.D., Kukkonen S., Vapalahti O., Plyusnin A., Lankinen H., and Vaheri A. Tula hantavirus infection of Vero E6 cells induces apoptosis involving caspase 8 activation. J. Gen. Virol. 85 Pt. 11 (2004) 3261-3268
22. Li X.D., Makela T.P., Guo D., Soliymani R., Koistinen V., Vapalahti O., Vaheri A., and Lankinen H. Hantavirus nucleocapsid protein interacts with the Fas-mediated apoptosis enhancer Daxx. J. Gen. Virol. 83 Pt. 4 (2002) 759-766
23. Lidington E.A., Moyes D.L., McCormack A.M., and Rose M.L. A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions. Transpl. Immunol. 7 4 (1999) 239-246
24. Linderholm M., and Elgh F. Clinical characteristics of hantavirus infections on the Eurasian continent. Curr. Top. Microbiol. Immunol. 256 (2001) 135-151
25. Maeda K., West K., Hayasaka D., Ennis F.A., and Terajima M. Recombinant adenovirus vector vaccine induces stronger cytotoxic T-cell responses than recombinant vaccinia virus vector, plasmid DNA, or a combination of these. Viral Immunol. 18 4 (2005) 657-667
26. Makela S., Mustonen J., Ala-Houhala I., Hurme M., Partanen J., Vapalahti O., Vaheri A., and Pasternack A. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J. Infect. Dis. 186 6 (2002) 843-846
27. Markotic A., Dasic G., Gagro A., Sabioncello A., Rabatic S., Kuzman I., Zgorelec R., Smoljan I., Beus I., Zupanc T.A., and Dekaris D. Role of peripheral blood mononuclear cell (PBMC) phenotype changes in the pathogenesis of haemorrhagic fever with renal syndrome (HFRS). Clin. Exp. Immunol. 115 2 (1999) 329-334
28. Markotic A., Hensley L., Geisbert T., Spik K., and Schmaljohn C. Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. J. Gen. Virol. 84 Pt. 8 (2003) 2197-2202
29. Meyer B.J., and Schmaljohn C.S. Persistent hantavirus infections: characteristics and mechanisms. Trends Microbiol. 8 2 (2000) 61-67
30. Milazzo M.L., Eyzaguirre E.J., Molina C.P., and Fulhorst C.F. Maporal viral infection in the Syrian golden hamster: a model of hantavirus pulmonary syndrome. J. Infect. Dis. 186 10 (2002) 1390-1395
31. Mori M., Rothman A.L., Kurane I., Montoya J.M., Nolte K.B., Norman J.E., Waite D.C., Koster F.T., and Ennis F.A. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J. Infect. Dis. 179 2 (1999) 295-302
32. Mustonen J., Helin H., Pietila K., Brummer-Korvenkontio M., Hedman K., Vaheri A., and Pasternack A. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin. Nephrol. 41 3 (1994) 121-126
33. Mustonen J., Partanen J., Kanerva M., Pietila K., Vapalahti O., Pasternack A., and Vaheri A. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand. J. Immunol. 47 3 (1998) 277-279
34. Niikura M., Maeda A., Ikegami T., Saijo M., Kurane I., and Morikawa S. Modification of endothelial cell functions by Hantaan virus infection: prolonged hyper-permeability induced by TNF-alpha of hantaan virus-infected endothelial cell monolayers. Arch. Virol. 149 7 (2004) 1279-1292
35. Nolte K.B., Feddersen R.M., Foucar K., Zaki S.R., Koster F.T., Madar D., Merlin T.L., McFeeley P.J., Umland E.T., and Zumwalt R.E. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum. Pathol. 26 1 (1995) 110-120
36. Obert G., Peiffer I., and Servin A.L. Rotavirus-induced structural and functional alterations in tight junctions of polarized intestinal Caco-2 cell monolayers. J. Virol. 74 10 (2000) 4645-4651
37. Pensiero M.N., Sharefkin J.B., Dieffenbach C.W., and Hay J. Hantaan virus infection of human endothelial cells. J. Virol. 66 10 (1992) 5929-5936
38. Peters C.J., and Zaki S.R. Role of the endothelium in viral hemorrhagic fevers. Crit. Care Med. 30 Suppl. 5 (2002) S268-S273
39. Schmaljohn A.L., Li D., Negley D.L., Bressler D.S., Turell M.J., Korch G.W., Ascher M.S., and Schmaljohn C.S. Isolation and initial characterization of a newfound hantavirus from California. Virology 206 2 (1995) 963-972
40. Schmaljohn C., and Hjelle B. Hantaviruses: a global disease problem. Emerg. Infect. Dis. 3 2 (1997) 95-104
41. Shaw S.K., Bamba P.S., Perkins B.N., and Luscinskas F.W. Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium. J. Immunol. 167 4 (2001) 2323-2330
42. Sundstrom J.B., McMullan L.K., Spiropoulou C.F., Hooper W.C., Ansari A.A., Peters C.J., and Rollin P.E. Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J. Virol. 75 13 (2001) 6070-6085
43. Takashima I., Morita K., Chiba M., Hayasaka D., Sato T., Takezawa C., Igarashi A., Kariwa H., Yoshimatsu K., Arikawa J., and Hashimoto N. A case of tick-borne encephalitis in Japan and isolation of the virus. J. Clin. Microbiol. 35 8 (1997) 1943-1947
44. Temonen M., Mustonen J., Helin H., Pasternack A., Vaheri A., and Holthofer H. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin. Immunol. Immunopathol. 78 1 (1996) 47-55
45. Terajima M., Van Epps H.L., Li D., Leporati A.M., Juhlin S.E., Mustonen J., Vaheri A., and Ennis F.A. Generation of recombinant vaccinia viruses expressing Puumala virus proteins and use in isolating cytotoxic T cells specific for Puumala virus. Virus Res. 84 1-2 (2002) 67-77
46. Terajima M., Vapalahti O., Van Epps H.L., Vaheri A., and Ennis F.A. Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica. Microbes Infect. 6 2 (2004) 238-245
47. Van Epps H.L., Schmaljohn C.S., and Ennis F.A. Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein. J. Virol. 73 7 (1999) 5301-5308
48. Van Epps H.L., Terajima M., Mustonen J., Arstila T.P., Corey E.A., Vaheri A., and Ennis F.A. Long-lived memory T lymphocyte responses after hantavirus infection. J. Exp. Med. 196 5 (2002) 579-588
49. Vapalahti O., Lundkvist A., and Vaheri A. Human immune response, host genetics, and severity of disease. Curr. Top. Microbiol. Immunol. 256 (2001) 153-169
50. Zaki S.R., Greer P.W., Coffield L.M., Goldsmith C.S., Nolte K.B., Foucar K., Feddersen R.M., Zumwalt R.E., Miller G.L., Khan A.S., et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol. 146 3 (1995) 552-579
51. Zeier M., Handermann M., Bahr U., Rensch B., Muller S., Kehm R., Muranyi W., and Darai G. New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention-a review. Virus Genes 30 2 (2005) 157-180
52. Zemmour J., Little A.M., Schendel D.J., and Parham P. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 148 6 (1992) 1941-1948